PeerVoice Oncology & Haematology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

subscribe
share






IAP Antagonists in Oncology: What Do We Know?


Visit https://www.peervoice.com/HDF860 to view the entire programme with slides. After completing “IAP Antagonists in Oncology: What Do We Know?”, participants will be able to: Describe the rationale for targeting IAP (inhibitor of apoptosis) in oncology; Identify the IAP antagonists most advanced in clinical development as anti-cancer treatments; and Evaluate how the clinical data for IAP antagonists are informing the potential for these agents in future clinical algorithms.


share








 2022-07-25  23m